TOP TIERMARKET NEWSWIRE
News & sentiment

BRAVEHEART BIO INC (BRVE) — News & AI sentiment

BRAVEHEART BIO INC (BRVE) news roundup. 4 stories in the past week, 19 over 30 days. Average 30-day sentiment is 59.8/100. Recent insider activity (SEC Form 4, 90-day window): 10 purchases totalling $159.0M and 0 sales totalling $0 — net buying of $159.0M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
4
avg sentiment 54.3/100
30d stories
19
avg sentiment 59.8/100
Insider net (90d)
$159.0M
10 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

BRVE news in the last 24 hours, 7 days, 30 days and 90 days

How much BRVE coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowBRVE storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days454.3/100BRVE headlines →
Last 30 days1959.8/100BRVE headlines →
Last 90 days4454.5/100BRVE headlines →

Latest stories on BRVE

Braveheart Bio, Inc. (BRVE) files 8-K
SEC 8-K50 · neutralgeneral
5d ago
Braveheart Bio, Inc. reports Q2 results
Seeking Alpha55 · neutralearnings
5d ago
5d ago
5d ago
Sep 1
Aug 31
Aug 31
Aug 31
Cantor Fitzgerald initiates Braveheart Bio stock with overweight rating
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
Jefferies starts biopharma firm Braveheart at Buy after IPO
Investing.com Markets63 · neutralanalyst
Aug 31
TD Cowen initiates Braveheart Bio stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
Aug 31
Aug 31
Aug 31
Aug 31
Aug 31
Stifel initiates Braveheart Bio stock with buy rating on HCM drug
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
Jefferies initiates Braveheart Bio stock with buy on heart drug potential
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
Goldman Sachs initiates Braveheart Bio stock coverage with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
Aug 10
Aug 10
Aug 10
Aug 10
Aug 10
Aug 10
Open BRVE in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →